Crown Capital Announces Anticipated Delay in Annual Filings and Application for Management Cease Trade Order

Executive Summary

• Crown Capital Partners Inc. anticipates a delay in filing its 15-month audited annual financial statements, MD&A, and related regulatory documents (originally due June 29, 2026) until approximately August 31, 2026.
• The delay is attributed to the late appointment of a successor independent auditor following the resignation of KPMG LLP on October 14, 2025.
• The company has applied to the Alberta Securities Commission for a Management Cease Trade Order (MCTO) to restrict trading by the CEO and CFO; failure to secure the MCTO or file on time could trigger a public Cease Trade Order halting all trading.

Key Details

• Delayed Filings: Audited annual financial statements, management’s discussion and analysis (MD&A), officer certifications, and annual information form for the 15-month period ended March 31, 2026.
• Original Filing Deadline: June 29, 2026 (per National Instrument 51-102 – Continuous Disclosure Obligations).
• Estimated New Filing Date: On or about August 31, 2026.
• Auditor Transition: KPMG LLP resigned at the Corporation’s request effective October 14, 2025. A successor auditor was formally engaged effective June 16, 2026, to audit the consolidated financial statements.
• Regulatory Application: Application submitted to the Alberta Securities Commission (ASC) for a Management Cease Trade Order (MCTO) under National Policy 12-203.
• MCTO Impact: If granted, trading in Crown’s securities will be restricted solely to the CEO and CFO; general public trading on the Toronto Stock Exchange (TSX: CRWN) would generally remain unaffected.
• Consequence of Denial: If the MCTO is denied and filings remain late, the ASC may issue a general public Cease Trade Order (CTO), which would halt all trading of the company’s securities.
• Alternative Information Guidelines: The company will issue bi-weekly status update news releases every 14 days following the default until the Annual Financial Filings are successfully filed.
• Regulatory Discretion: The granting of the MCTO is at the ASC's discretion, and there is no guarantee it will be approved.